LOIS HARRIMAN: Open Payments
NPI 1558532952 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 43 payments from 8 companies in 2025. Trend: 2023 $2,451 · 2024 $1,670 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $242 |
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Janssen Pharmaceuticals, Inc | 8 | $157 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, INGREZZA, CAPLYTA, AUSTEDO XR, UZEDY.
Industry payments across FL — which companies pay providers there.
